The Role of BioPhotonics in
Open Data and Open Science
Jean-François Dechamp
European Commission, Directorate-General for Research &
Innovation
Pointers following the panel on 21 April 2020
• Open science website
• Open access website (a bit of history, not necessarily updated anymore)
• Open access in Horizon 2020 website
European Commission as a funder
• Council conclusions on open, data-intensive and networked research as a
driver for faster and wider innovation (2015)
• Council conclusions on the transition towards an open science system (2016)
• Council conclusions on accelerating knowledge circulation in the EU (2018)
• ERAC Standing Working Group on Open Science and Innovation (SWG OSI)
• Recommendations on open science (2018)
• Opinion on open innovation (2019)
• Opinion on future open science and open innovation priorities in the European Research
Area 2020-2030 (2020)
EU Member States and open science
• Immediate open access (already in Horizon Europe’s impact assessment)
• Embargoes not accepted any longer
• Open access via repositories kept
• Publication in hybrid journals allowed yet not funded (Already in impact assessment)
• i.e. costs not eligible
• Copyright retention and open license
• Copyright retention already in the HE Regulation
• Open license to be required (in line with new standard for EC’s own information production)
Proposals for Horizon Europe (tbc)
• Revised Recommendations on access to and preservation of scientific information (2018)
• Why this pointer? It sets the landscape for OS with a view to tackle disparities
• Revised Copyright Directive (2019)
• Why this pointer? It provides for an exception for research organisations to carry out text and data mining (data
analytics)
• Revised Open data Directive (2019)
• Why this pointer? It enshrines ‘As open as possible, as closed as necessary’
• New Communication on a European Data Strategy (2020)
• Why this pointer? Its our most recent document, which aims at creating a Common European Data Space (incl.
European Open Science Cloud)
Open science in the EU legislation
• I did not mention it but it’s an interesting move.
• Why a platform? To help H2020 beneficiaries and their researchers
comply with the open access mandate without paying APCs during and
after the grant
• Who? F1000 with the support of Eurodoc, Global Young Academy and
LIBER
• When? Beta version to be ready by autumn 2020 and official launch
scheduled for late 2020 / early 2021
A funder’s publishing platform
• European Commission's action on coronavirus (official page)
• Check in particular https://www.covid19dataportal.org/ and press release
https://ec.europa.eu/commission/presscorner/detail/en/ip_20_680
• First ERAvsCorona action plan: short-term coordinated R&I actions
• Is this a wakeup call for open science and open access? Will this pandemic have a
permanent effect on R&I policy, where SARS, Zika or H1N1 epidemics failed on such
capitalization?
• Careful to read fine lines (e.g. licences and permanence of COVID-19 collections in PubMed
Central (PMC) as custom license may specify that open access to the papers is temporary)
Covid 19

Open Data and Open Science in the European Commission

  • 1.
    The Role ofBioPhotonics in Open Data and Open Science Jean-François Dechamp European Commission, Directorate-General for Research & Innovation Pointers following the panel on 21 April 2020
  • 2.
    • Open sciencewebsite • Open access website (a bit of history, not necessarily updated anymore) • Open access in Horizon 2020 website European Commission as a funder
  • 3.
    • Council conclusionson open, data-intensive and networked research as a driver for faster and wider innovation (2015) • Council conclusions on the transition towards an open science system (2016) • Council conclusions on accelerating knowledge circulation in the EU (2018) • ERAC Standing Working Group on Open Science and Innovation (SWG OSI) • Recommendations on open science (2018) • Opinion on open innovation (2019) • Opinion on future open science and open innovation priorities in the European Research Area 2020-2030 (2020) EU Member States and open science
  • 4.
    • Immediate openaccess (already in Horizon Europe’s impact assessment) • Embargoes not accepted any longer • Open access via repositories kept • Publication in hybrid journals allowed yet not funded (Already in impact assessment) • i.e. costs not eligible • Copyright retention and open license • Copyright retention already in the HE Regulation • Open license to be required (in line with new standard for EC’s own information production) Proposals for Horizon Europe (tbc)
  • 5.
    • Revised Recommendationson access to and preservation of scientific information (2018) • Why this pointer? It sets the landscape for OS with a view to tackle disparities • Revised Copyright Directive (2019) • Why this pointer? It provides for an exception for research organisations to carry out text and data mining (data analytics) • Revised Open data Directive (2019) • Why this pointer? It enshrines ‘As open as possible, as closed as necessary’ • New Communication on a European Data Strategy (2020) • Why this pointer? Its our most recent document, which aims at creating a Common European Data Space (incl. European Open Science Cloud) Open science in the EU legislation
  • 6.
    • I didnot mention it but it’s an interesting move. • Why a platform? To help H2020 beneficiaries and their researchers comply with the open access mandate without paying APCs during and after the grant • Who? F1000 with the support of Eurodoc, Global Young Academy and LIBER • When? Beta version to be ready by autumn 2020 and official launch scheduled for late 2020 / early 2021 A funder’s publishing platform
  • 7.
    • European Commission'saction on coronavirus (official page) • Check in particular https://www.covid19dataportal.org/ and press release https://ec.europa.eu/commission/presscorner/detail/en/ip_20_680 • First ERAvsCorona action plan: short-term coordinated R&I actions • Is this a wakeup call for open science and open access? Will this pandemic have a permanent effect on R&I policy, where SARS, Zika or H1N1 epidemics failed on such capitalization? • Careful to read fine lines (e.g. licences and permanence of COVID-19 collections in PubMed Central (PMC) as custom license may specify that open access to the papers is temporary) Covid 19